RFP
Closed:

Seeking Phenotypic Cellular Assays Relating to Rare Disease

Seeking Phenotypic Cellular Assays Relating to Rare Disease

Takeda Pharmaceutical Company Ltd. has developed a curated kinase inhibitor library, selected from profiling against more than 300 protein kinases. To foster partnerships based on complementary strengths between academia and industry, they are seeking researchers with access to cell-based phenotypic assays related to rare disease. Successful applicants will receive up to $15,000 USD for project costs (however, this can be increased where necessary with the exact funding amount at Takeda’s discretion) to test the library in their own laboratory. Additionally...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Responses

  • Applicants must use the submission template when preparing a response outlining a research project proposal

Essential Information

Submission Form

Share this call with professional partners.